Regulation of interferon-dependent mRNA translation of target genes

Journal of Interferon and Cytokine Research

Volumn 34, Issue 4, 2014, Pages 289-296

  Kroczynska, Barbara ^a   Mehrotra, Swarna ^a   Arslan, Ahmet Dirim ^a   Kaur, Surinder ^a   Platanias, Leonidas C ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 4B; INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN 1; INTERFERON; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROGRAMMED CELL DEATH 4 PROTEIN; PROTEIN; PROTEIN KINASE B; PROTEIN S6; UNCLASSIFIED DRUG; ALPHA BETA INTERFERON RECEPTOR; GAMMA INTERFERON; INTERFERON RECEPTOR; INTERFERON RECEPTOR, TYPE II; MITOGEN ACTIVATED PROTEIN KINASE 1; TARGET OF RAPAMYCIN KINASE;

ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME REGULATION; GENE TARGETING; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSLATION INITIATION; ANIMAL; AUTOIMMUNE DISEASE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; NEOPLASM; VIRUS INFECTION;

ANIMALS; AUTOIMMUNE DISEASES; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE I; INTERFERON-GAMMA; MITOGEN-ACTIVATED PROTEIN KINASE 1; NEOPLASMS; PROTEIN BIOSYNTHESIS; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; VIRUS DISEASES;

EID: 84898762741     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2013.0148     Document Type: Review

References (97)

1. Anjum R, Blenis J. 2008. The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol 9(10): 747-758.
2. Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR. 2006. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol 80(9):4501-4509.
3. Berry MJ, Knutson GS, Lasky SR, Munemitsu SM, Samuel CE. 1985. Mechanism of interferon action. Purification and substrate specificities of the double-stranded RNA-dependent protein kinase from untreated and interferon-treated mouse fibroblasts. J Biol Chem 260(20):11240-11247.
4. Bi X, Ren J, Goss DJ. 2000. Wheat germ translation initiation factor eIF4B affects eIF4A and eIFiso4F helicase activity by increasing the ATP binding affinity of eIF4A. Biochemistry 39(19):5758-5765.
5. Boehm U, Klamp T, Groot M, Howard JC. 1997. Cellular responses to interferon-gamma. Annu Rev Immunol 15: 749-795.
6. Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, Stark GR. 2007. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 6(12):975-990.
7. Borden EC, Williams BR. 2011. Interferon-stimulated genes and their protein products: what and how? J Interferon Cytokine Res 31(1):1-4.
8. Burke JD, Sonenberg N, Platanias LC, Fish EN. 2011. Antiviral effects of interferon-b are enhanced in the absence of the translational suppressor 4E-BP1 in myocarditis induced by Coxsackievirus B3. Antivir Ther 16(4):577-584.
9. Carriere A, Ray H, Blenis J, Roux PP. 2008. The RSK factors of activating the Ras/MAPK signaling cascade. Front Biosci 13:4258-4275.
10. Carroll M, Borden KL. 2013. The oncogene eIF4E: using biochemical insights to target cancer. J Interferon Cytokine Res 33(5):227-238.
11. Darnell JE, Jr., Kerr IM, Stark GR. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264(5164):1415-1421.
12. David M, Petricoin E 3rd, Benjamin C, Pine R, Weber MJ, Larner AC. 1995. Requirement for MAP kinase (ERK2) activity in interferon alpha-and interferon beta-stimulated gene expression through STAT proteins. Science 269(5231):1721-1723.
13. Dobrikov M, Dobrikova E, Shveygert M, Gromeier M. 2011. Phosphorylation of eukaryotic translation initiation factor 4G1 (eIF4G1) by protein kinase C{alpha} regulates eIF4G1 binding to Mnk1. Mol Cell Biol 31(14):2947-2959.
14. Donnelly RP, Kotenko SV. 2010. Interferon-lambda: a new addition to an old family. J Interferon Cytokine Res 30(8): 555-564.
15. Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M. 2006. S6K1-and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314(5798):467-471.
16. Ezell SA, Polytarchou C, Hatziapostolou M, Guo A, Sanidas I, Bihani T, Comb MJ, Sourvinos G, Tsichlis PN. 2012. The protein kinase Akt1 regulates the interferon response through phosphorylation of the transcriptional repressor EMSY. Proc Natl Acad Sci USA 109(10):E613-E621.
17. Flotow H, Thomas G. 1992. Substrate recognition determinants of the mitogen-activated 70K S6 kinase from rat liver. J Biol Chem 267(5):3074-3078.
18. Frescas D, Pagano M. 2008. Deregulated proteolysis by the Fbox proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer 8(6):438-449.
19. Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aebersold R, Sonenberg N. 1999a. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev 13(11):1422-1437.
20. Gingras AC, Raught B, Sonenberg N. 1999b. EIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation Annu Rev Biochem, 68:913-963.
21. Goncharova EA, Lim PN, Chisolm A, Fogle HW 3rd, Taylor JH, Goncharov DA, Eszterhas A, Panettieri RA, Jr., Krymskaya VP. 2010. Interferons modulate mitogen-induced protein synthesis in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 299(1):L25-L35.
22. Grifo JA, Abramson RD, Satler CA, Merrick WC. 1984. RNAstimulated ATPase activity of eukaryotic initiation factors J Biol Chem 259(13):8648-8654.
23. Hay N, Sonenberg N. 2004. Upstream and downstream of mTOR. Genes Dev 18(16):1926-1945.
24. Hershey JW, Sonenberg N, Mathews MB. 2012. Principles of translational control: an overview. Cold Spring Harb Perspect Biol 4(12):pii: a011528.
25. Holz MK, Ballif BA, Gygi SP, Blenis J. 2005. mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123(4):569-580.
26. Huang H, Kang R, Wang J, Luo G, Yang W, Zhao Z. 2013. Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy. Autophagy 9(2):175-195.
27. Isaacs A, Lindenmann J. 1957. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147(927):258-267.
28. Isaacs A, Lindenmann J, Valentine RC. 1957. Virus interference. II. Some properties of interferon. Proc R Soc Lond B Biol Sci 147(927):268-273.
29. Jaramillo M, Dever TE, Merrick WC, Sonenberg N. 1991. RNA unwinding in translation: assembly of helicase complex intermediates comprising eukaryotic initiation factors eIF-4F and eIF-4B. Mol Cell Biol 11(12):5992-5997.
30. Jefferies HB, Fumagalli S, Dennis PB, Reinhard C, Pearson RB, Thomas G. 1997. Rapamycin suppresses 5¢TOP mRNA translation through inhibition of p70s6k. EMBO J 16(12):3693-3704.
31. Joshi S, Kaur S, Kroczynska B, Platanias LC. 2010. Mechanisms of mRNA translation of interferon stimulated genes. Cytokine 52(1-2):123-127.
32. Joshi S, Kaur S, Redig AJ, Goldsborough K, David K, Ueda T, Watanabe-Fukunaga R, Baker DP, Fish EN, Fukunaga R, Platanias LC. 2009. Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses. Proc Natl Acad Sci USA 106(29): 12097-12102.
33. Joshi S, Platanias LC. 2012. Mnk kinases in cytokine signaling and regulation of cytokine responses. Biomol Concepts 3(2): 127-139.
34. Joshi S, Sharma B, Kaur S, Majchrzak B, Ueda T, Fukunaga R, Verma AK, Fish EN, Platanias LC. 2011. Essential role for Mnk kinases in type II interferon (IFNgamma) signaling and its suppressive effects on normal hematopoiesis. J Biol Chem 286(8):6017-6026.
35. Katsoulidis E, Carayol N, Woodard J, Konieczna I, Majchrzak-Kita B, Jordan A, Sassano A, Eklund EA, Fish EN, Platanias LC. 2009. Role of Schlafen 2 (SLFN2) in the generation of interferon alpha-induced growth inhibitory responses. J Biol Chem 284(37):25051-25064.
36. Katsoulidis E, Mavrommatis E, Woodard J, Shields MA, Sassano A, Carayol N, Sawicki KT, Munshi HG, Platanias LC. 2010. Role of interferon {alpha} (IFN{alpha})-inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells. J Biol Chem 285(51):40333-40341.
37. Kaur S, Lal L, Sassano A, Majchrzak-Kita B, Srikanth M, Baker DP, Petroulakis E, Hay N, Sonenberg N, Fish EN, Platanias LC. 2007. Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling. J Biol Chem 282(3):1757-1768.
38. Kaur S, Sassano A, Dolniak B, Joshi S, Majchrzak-Kita B, Baker DP, Hay N, Fish EN, Platanias LC. 2008a. Role of the Akt pathway in mRNA translation of interferon-stimulated genes. Proc Natl Acad Sci USA 105(12):4808-4813.
39. Kaur S, Sassano A, Joseph AM, Majchrzak-Kita B, Eklund EA, Verma A, Brachmann SM, Fish EN, Platanias LC. 2008b. Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling. J Immunol 181(10):7316-7323.
40. Kaur S, Sassano A, Majchrzak-Kita B, Baker DP, Su B, Fish EN, Platanias LC. 2012. Regulatory effects of mTORC2 complexes in type I IFN signaling and in the generation of IFN responses. Proc Natl Acad Sci USA 109(20):7723-7728.
41. Kolch W. 2005. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 6(11): 827-837.
42. Kong J, Lasko P. 2012. Translational control in cellular and developmental processes. Nat Rev Genet 3(6):383-394.
43. Kotenko SV, Langer JA. 2004. Full house: 12 receptors for 27 cytokines. Int Immunopharmacol 4(5):593-608.
44. Kroczynska B, Joshi S, Eklund EA, Verma A, Kotenko SV, Fish EN, Platanias LC. 2011. Regulatory effects of ribosomal S6 kinase 1 (RSK1) in IFNl signaling. J Biol Chem 286(2):1147-1156.
45. Kroczynska B, Kaur S, Katsoulidis E, Majchrzak-Kita B, Sassano A, Kozma SC, Fish EN, Platanias LC. 2009. Interferondependent engagement of eukaryotic initiation factor 4B via S6 kinase (S6K)-and ribosomal protein S6K-mediated signals. Mol Cell Biol 29(10):2865-2875.
46. Kroczynska B, Sharma B, Eklund EA, Fish EN, Platanias LC. 2012. Regulatory effects of programmed cell death 4 (PDCD4) protein in interferon (IFN)-stimulated gene expression and generation of type I IFN responses. Mol Cell Biol 32(14):2809-2822.
47. Lankat-Buttgereit B, Göke R. 2009. The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell 101(6):309-317.
48. Laplante M, Sabatini DM. 2012. mTOR signaling in growth control and disease. Cell 149(2):274-293.
49. Lekmine F, Sassano A, Uddin S, Smith J, Majchrzak B, Brachmann SM, Hay N, Fish EN, Platanias LC. 2004. Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein. Exp Cell Res 295(1):173-182.
50. Lekmine F, Uddin S, Sassano A, Parmar S, Brachmann SM, Majchrzak B, Sonenberg N, Hay N, Fish EN, Platanias LC. 2003. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons. J Biol Chem 278(30):27772-27780.
51. Lindenmann J, Burke DC, Isaacs A. 1957. Studies on the production, mode of action and properties of interferon. Br J Exp Pathol 38(5):551-562.
52. Ma XM, Blenis J. 2009. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10(5):307-318.
53. MacMicking JD. 2012. Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat Rev Immunol 12(5): 367-382.
54. Matsumoto A, Ichikawa T, Nakao K, Miyaaki H, Hirano K, Fujimito M, Akiyama M, Miuma S, Ozawa E, Shibata H, Takeshita S, Yamasaki H, Ikeda M, Kato N, Eguchi K. 2009. Interferon-alpha-induced mTOR activation is an anti-hepatitis C virus signal via the phosphatidylinositol 3-kinase-Aktindependent pathway. J Gastroenterol 44(8):856-863.
55. Mavrommatis E, Fish EN, Platanias LC. 2013. The schlafen family of proteins and their regulation by interferons. J Interferon Cytokine Res 33(4):206-210.
56. Mehrotra S, Sharma B, Joshi S, Kroczynska B, Majchrzak B, Stein BL, McMahon B, Altman JK, Licht JD, Baker DP, Eklund EA, Wickrema A, Verma A, Fish EN, Platanias LC. 2013. Essential role for the Mnk-pathway in the inhibitory effects of Type I interferons on myeloproliferative neoplasm (MPN) precursors. J Biol Chem 288(33):23814-23822.
57. Mendoza MC, Er EE, Blenis J. 2011. The Ras-ERK and PI3KmTOR pathways: cross-talk and compensation. Trends Biochem Sci 36(6):320-328.
58. Méthot N, Song MS, Sonenberg N. 1996. A region rich in aspartic acid, arginine, tyrosine, and glycine (DRYG) mediates eukaryotic initiation factor 4B (eIF4B) self-association and interaction with eIF3. Mol Cell Biol 16(10):5328-5334.
59. Nagano Y, Kojima Y. 1954. Pouvoir immunisant du virus vaccinal inactivé par des rayons ultraviolets. C R Seances Soc Biol Fil 148(19-20):1700-1702.
60. Palamarchuk A, Efanov A, Maximov V, Aqeilan RI, Croce CM, Pekarsky Y. 2005. Akt phosphorylates and regulates Pdcd4 tumor suppressor protein. Cancer Res 65(24):11282-11286.
61. Panaretakis T, Hjortsberg L, Tamm KP, Björklund AC, Joseph B, Grandér D. 2008. Interferon alpha induces nucleus-independent apoptosis by activating extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase downstream of phosphatidylinositol 3-kinase and mammalian target of rapamycin. Mol Biol Cell 19(1):41-50.
62. Parmar S, Platanias LC. 2003. Interferons: mechanisms of action and clinical applications. Curr Opin Oncol 15(6): 431-439.
63. Parsyan A, Svitkin Y, Shahbazian D, Gkogkas C, Lasko P, Merrick WC, Sonenberg N. 2011. mRNA helicases: the tacticians of translational control. Nat Rev Mol Cell Biol 12(4):235-245.
64. Pende M, Um SH, Mieulet V, Sticker M, Goss VL, Mestan J, MuellerM, Fumagalli S, Kozma SC, Thomas G. 2004. S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycinsensitive 5¢-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Biol 24(8):3112-3124.
65. Pestka S. 2007. The interferons: 50 years after their discovery, there is much more to learn. J Biol Chem 282(28):20047-20051.
66. Pestka S, Krause CD, Walter MR. 2004. Interferons, interferonlike cytokines, and their receptors. Immunol Rev 202:8-32.
67. Petković F, Blazevski J, Momcilović M, Timotijević G, Zocca MB, Mijatović S, Maksimović-Ivanić D, Mangano K, Fagone P, Stosić-Grujicić S, Nicoletti F, Miljković D. 2013. Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferongamma and ameliorates experimental autoimmune encephalomyelitis. J Neuroimmunol 259(1-2):55-65.
68. Platanias LC. 2003a. The p38 mitogen-activated protein kinase pathway and its role in interferon signaling. Pharmacol Ther 98(2):129-142.
69. Platanias LC. 2003b. Map kinase signaling pathways and hematologic malignancies. Blood 101(12):4667-4679.
70. Platanias LC. 2005a. Mechanisms of type-I-and type-II-interferonmediated signalling. Nat Rev Immunol 5(5):375-386.
71. Platanias LC. 2005b. Introduction: interferon signals: what is classical and what is nonclassical? J Interferon Cytokine Res 25(12):732.
72. Platanias LC, Fish EN. 1999. Signaling pathways activated by interferons. Exp Hematol 27(11):1583-1592.
73. Raught B, Peiretti F, Gingras AC, Livingstone M, Shahbazian D, Mayeur GL, Polakiewicz RD, Sonenberg N, Hershey JW. 2004. Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. EMBO J 23(8):1761-1769.
74. Redig AJ, Sassano A, Majchrzak-Kita B, Katsoulidis E, Liu H, Altman JK, Fish EN, Wickrema A, Platanias LC. 2009. Activation of protein kinase C{eta} by type I interferons. J Biol Chem 284(16):10301-10314.
75. Richter JD, Sonenberg N. 2005. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 433(7025): 477-480.
76. Rosner D, Stoneman V, Littlewood T, McCarthy N, Figg N, Wang Y, Tellides G, Bennett M. 2006. Interferon-gamma induces Fas trafficking and sensitization to apoptosis in vascular smooth muscle cells via a PI 3¢K-and Akt-dependent mechanism. Am J Pathol 168(6):2054-2063.
77. Roux PP, Shahbazian D, Vu H, Holz MK, Cohen MS, Taunton J, Sonenberg N, Blenis J. 2007. RAS/ERK signaling pro-motes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation. J Biol Chem 282(19):14056-14064.
78. Rozengurt E. 2007. Mitogenic signaling pathways induced by G protein-coupled receptors. J Cell Physiol 213(3):589-602.
79. Schaeffer HJ, Weber MJ. 1999. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 19(4):2435-2444.
80. Schoggins JW, Rice CM. 2011. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 1(6): 519-525.
81. Seo Y, Kim M, Choi M, Kim S, Park K, Oh I, Chung S, Suh H, Hong S, Park S. 2011. Possible role of phosphoinositide-3-kinase in Mx1 protein translation and antiviral activity of interferon-omega-stimulated HeLa cells. Pharmacology 87 (3-4):224-231.
82. Shahbazian D, Roux PP, Mieulet V, Cohen MS, Raught B, Taunton J, Hershey JW, Blenis J, Pende M, Sonenberg N. 2006. The mTOR/PI 3¢K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J 25(12):2781-2791.
83. Sharma B, Joshi S, Sassano A, Majchrzak B, Kaur S, Aggarwal P, Nabet B, Bulic M, Stein BL, McMahon B, Baker DP, Fukunaga R, Altman JK, Licht JD, Fish EN, Platanias LC. 2012. Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responses. J Biol Chem 287(50):42352-42360.
84. Sheikh MS, Fornace AJ, Jr. 1999. Regulation of translation initiation following stress. Oncogene 18(45):6121-6128.
85. Sonenberg N, Hinnebusch AG. 2009. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136(4):731-745.
86. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. 1998. How cells respond to interferons. Annu Rev Biochem 67:227-264.
87. Suzuki C, Garces RG, Edmonds KA, Hiller S, Hyberts SG, Marintchev A, Wagner G. 2008. PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains. Proc Natl Acad Sci USA 105(9):3274-3279.
88. Tarhini AA, Gogas H, Kirkwood JM. 2012. IFN-a in the treatment of melanoma. J Immunol 189(8):3789-3793.
89. Thyrell L, Hjortsberg L, Arulampalam V, Panaretakis T, Uhles S, Dagnell M, Zhivotovsky B, Leibiger I, Grandér D, Pokrovskaja K. 2004. Interferon alpha-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase/mammalian target of rapamycin signaling pathway. J Biol Chem 279(23):24152-24162.
90. Uddin S, Fish EN, Sher DA, Gardziola C, White MF, Platanias LC. 1997. Activation of the phosphatidylinositol 3-kinase serine kinase by IFN-alpha. J Immunol 158(5):2390-2397.
91. Uddin S, Lekmine F, Sharma N, Majchrzak B, Mayer I, Young PR, Bokoch GM, Fish EN, Platanias LC. 2000. The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins. J Biol Chem 275(36): 27634-27640.
92. Uddin S, Majchrzak B, Woodson J, Arunkumar P, Alsayed Y, Pine R, Young PR, Fish EN, Platanias LC. 1999. Activation of the p38 mitogen-activated protein kinase by type I interferons. J Biol Chem 274(42):30127-30131.
93. Uddin S, Sassano A, Deb DK, Verma A, Majchrzak B, Rahman A, Malik AB, Fish EN, Platanias LC. 2002. Protein kinase Cdelta (PKC-delta) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J Biol Chem 277(17):14408-14416.
94. Uddin S, Yenush L, Sun XJ, Sweet ME, White MF, Platanias LC. 1995. Interferon-alpha engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3'-kinase. J Biol Chem 270(27):15938-15941.
95. Wang BX, Fish EN. 2012. The yin and yang of viruses and interferons. Trends Immunol 33(4):190-197.
96. Waskiewicz AJ, Flynn A, Proud CG, Cooper JA. 1997. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J 16(8):1909-1920.
97. Zoncu R, Efeyan A, Sabatini DM. 2011. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12(1):21-35.